Department of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Department of Medicine, Division of Nephrology, Baylor College of Medicine, Houston, TX, USA.
J Mol Med (Berl). 2018 Jul;96(7):631-644. doi: 10.1007/s00109-018-1648-3. Epub 2018 May 22.
Mutations in canonical transient receptor potential-6 (TRPC6) channels give rise to rare familial forms of focal and segmental glomerulosclerosis (FSGS). Here we examined a possible role for TRPC6 in the progression of chronic puromycin aminonucleoside (PAN) nephrosis in Sprague-Dawley rats, a classic model of acquired nephrotic syndromes. We used CRISPR/Cas9 technology to delete a 239-bp region within exon 2 of the Trpc6 gene (Trpc6 allele). Trpc6 rats expressed detectable Trpc6 transcripts missing exon 2, and TRPC6 proteins could be detected by immunoblot of renal cortex. However, the abundance of Trpc6 transcripts and TRPC6 protein in renal cortex was much lower than in Trpc6 littermates, and functional TRPC6 channels could not be detected in whole-cell recordings from glomerular cells cultured from Trpc6 animals, possibly because of disruption of ankyrin repeats 1 and 2. During the chronic phase of PAN nephrosis, Trpc6 rats had reduced urine albumin excretion, reduced serum cholesterol and triglycerides, and improved azotemia compared to wild-type Trpc6 littermates. Glomerulosclerosis was severe during chronic PAN nephrosis in Trpc6 rats but was markedly reduced in Trpc6 littermates. Trpc6 animals also had less severe tubulointerstitial fibrosis as assessed by several biochemical and histological analyses, as well as reduced foot process effacement and glomerular basement thickening compared to Trpc6 controls. None of the manipulations in this study affected the abundance of TRPC5 channels in renal cortex. TRPC3 was increased in PAN nephrosis and in Trpc6 rats. These data support a role for TRPC6 channels in driving an acquired form of secondary FSGS.
We examined aminonucleoside nephrosis in rats with wild type and inactivated TRPC6. TRPC6 channels were inactivated by CRISPR/Cas9 editing of the Trpc6 gene. TRPC6 inactivation reduced albuminuria in the chronic but not the acute phase. TRPC6 inactivation reduced glomerulosclerosis and ultrastructural changes. TRPC6 inactivation also reduced interstitial changes and renal fibrosis.
研究野生型和 TRPC6 失活大鼠的氨基核苷肾病。方法:采用 CRISPR/Cas9 技术对 Trpc6 基因第 2 外显子的 239bp 区域进行缺失(Trpc6 等位基因)。结果:TRPC6 失活大鼠的肾脏皮质可检测到缺失外显子 2 的 Trpc6 转录本,但 Trpc6 转录本和 TRPC6 蛋白的丰度明显低于野生型同窝仔鼠,且无法从 TRPC6 动物肾小球细胞的全细胞记录中检测到功能性 TRPC6 通道,可能是由于锚蛋白重复 1 和 2 被破坏。在 PAN 肾病的慢性期,与野生型 Trpc6 同窝仔鼠相比,TRPC6 大鼠的尿白蛋白排泄减少,血清胆固醇和甘油三酯降低,氮血症改善。与野生型 Trpc6 同窝仔鼠相比,TRPC6 大鼠的肾小球硬化更为严重,但在 TRPC6 失活大鼠中明显减少。通过多种生化和组织学分析,以及与 TRPC6 对照相比足突融合和肾小球基底膜增厚的减少,TRPC6 动物的肾小管间质纤维化也较轻。本研究中的任何操作均不影响肾脏皮质中 TRPC5 通道的丰度。TRPC3 在 PAN 肾病和 TRPC6 大鼠中增加。这些数据支持 TRPC6 通道在驱动获得性继发性 FSGS 中的作用。
我们研究了野生型和 TRPC6 失活大鼠的氨基核苷肾病。TRPC6 通道通过 Trpc6 基因的 CRISPR/Cas9 编辑失活。TRPC6 失活减少了慢性而非急性阶段的蛋白尿。TRPC6 失活减少了肾小球硬化和超微结构改变。TRPC6 失活还减少了间质变化和肾纤维化。